These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25237649)

  • 21. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
    Pinelli A; Trivulzio S; Spezia R
    Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.
    Ritzmann RF
    Pharmacol Biochem Behav; 1981 Apr; 14(4):575-7. PubMed ID: 7195040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinociceptive activity and effect of methanol extracts of three salvia spp. On withdrawal syndrome in mice.
    Karami M; Shamerani MM; Hossini E; Gohari AR; Ebrahimzadeh MA; Nosrati A
    Adv Pharm Bull; 2013; 3(2):457-9. PubMed ID: 24312878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of low-intensity laser therapy on naloxone-precipitated morphine withdrawal signs in mice: is nitric oxide a possible candidate mediator?
    Ojaghi R; Sohanaki H; Ghasemi T; Keshavarz F; Yousefifard M; Sadeghipour HR
    Lasers Med Sci; 2014 Sep; 29(5):1655-9. PubMed ID: 24711009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Salvia leriifolia leaf extract on morphine dependence in mice.
    Hosseinzadeh H; Lary P
    Phytother Res; 2000 Aug; 14(5):384-7. PubMed ID: 10925411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
    Fukase H; Fukuzaki K; Koja T; Nagata R; Lukas SE
    Psychopharmacology (Berl); 1994 Dec; 116(4):396-400. PubMed ID: 7701039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine.
    Vela G; Ruiz-Gayo M; Fuentes JA
    Neuropharmacology; 1995 Jun; 34(6):665-8. PubMed ID: 7566503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of orexin type-1 receptors (OX1Rs) attenuates naloxone-precipitated morphine withdrawal syndrome in rat dorsal hippocampus.
    Hooshmandi M; Hosseinmardi N; Janahmadi M; Khakpai F; Rohampour K; Doostmohammadi J
    Pharmacol Biochem Behav; 2017 Jul; 158():39-48. PubMed ID: 28583577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-administration of calcium gluconate and magnesium acetate effectively blocks the signs of morphine withdrawal in mice.
    Rabbani M; Hajhashemi V; Vadizadeh A
    Magnes Res; 2012 Mar; 25(1):40-8. PubMed ID: 22429988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronopharmacological study of physical dependence on morphine in rats].
    Suzuki T; Shimada M; Yoshii T; Kawamura M; Yanaura S
    Nihon Yakurigaku Zasshi; 1985 Jan; 85(1):17-22. PubMed ID: 4039289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative opioid withdrawal signs in rats: effects exerted by clothiapine administration.
    Pinelli A; Trivulzio S; Ciapponi PM
    Fundam Clin Pharmacol; 1997; 11(4):346-55. PubMed ID: 9263765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
    Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice.
    Wen D; Zhao P; Hui R; Wang J; Shen Q; Gong M; Guo H; Cong B; Ma C
    Neuropharmacology; 2017 May; 118():199-208. PubMed ID: 28359771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.
    Zhang Z; Schulteis G
    Pharmacol Biochem Behav; 2008 May; 89(3):392-403. PubMed ID: 18308382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute administration of pioglitazone attenuates morphine withdrawal syndrome in rat: a novel role of pioglitazone.
    Ghavimi H; Azarfardian A; Maleki-Dizaji N; Hassanzadeh K; Ghanbarzadeh S; Charkhpour M
    Drug Res (Stuttg); 2015 Mar; 65(3):113-8. PubMed ID: 24504689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method of reducing the opioid withdrawal intensity using progressively increasing doses of naloxone.
    Langerman L; Steingart RA; Margolis A; Yanai J
    J Pharmacol Toxicol Methods; 1999 Nov; 42(3):115-9. PubMed ID: 10964008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
    de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
    Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of a 5-HT7 receptor agonist and antagonist on morphine withdrawal syndrome in mice.
    Shahidi S; Hashemi-Firouzi N
    Neurosci Lett; 2014 Aug; 578():27-32. PubMed ID: 24954075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.